Developing the next generation of cardiac markers: disease-induced modifications of troponin I.
about
Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failureThe use of proteomics to identify novel therapeutic targets for the treatment of disease.Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus.Cardiovascular proteomics: implications for clinical applicationsPost-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophyProtein analysis by shotgun/bottom-up proteomicsInclusion of biomarkers for detecting perturbations in the heart and lung and lipid/carbohydrate metabolism in National Toxicology Program studies.Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights.A proteomic primer for the clinicianThe impact of antibody selection on the detection of cardiac troponin I.Antithrombin is protective against myocardial ischemia and reperfusion injury.New potential uses for cardiac troponins.Comparative study of P19 EC stem cell differentiation in between conventional hanging drop and the zebrafish chorion as a bio-derived material.Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice.Evaluation of a newly developed chemiluminescence immunoassay for detecting cardiac troponin T.Cardiac troponins: from myocardial infarction to chronic disease.The continuing evolution of cardiac troponin I biomarker analysis: from protein to proteoform.Retrospective diagnosis of hypoxic myocardial injury in premature newborns.The Future: Translation from Discovery to the Clinic - Roles of HUPO and Industry in Biomarker Discovery
P2860
Q28243166-D3F4F56B-6148-48C3-8A2C-E0DD612B9547Q30361936-5A65E388-DDAE-45BD-AD84-0262CC7276EDQ33552596-2F9D6D33-E6DD-44C1-91F0-6E477C8821F0Q33579184-953A58EE-D88A-49EE-8B50-E54B6A243D5DQ33838145-1E73DC8D-CC6B-4643-BF71-CCA08E710410Q34600986-B57D3693-4860-417A-A1F3-3750E2B6C6E2Q36148595-648614EB-9C26-46E7-B105-01A48075B070Q36491992-AB444851-8CA1-4D18-A1E8-1C6F338D8B8BQ36698789-B1BCB2BF-ED46-455E-9CC8-8CE1E55B2241Q36781774-A324B397-1365-4841-B900-8A70A63F8BBDQ36986076-356405F3-3B9B-4FFE-AD0E-B02186BF31D7Q37755057-48F12612-D148-426F-8CAA-1A9586ED191FQ40025204-802027C1-2C30-491E-AE6B-AF77EBCB9432Q41248958-5531BF6B-6591-486A-AEB4-6CDF51F7C095Q41994970-A0D3590C-26E1-4D7D-B952-FA4F8012F35BQ47671109-52FDCDA7-4179-49DC-9689-23A6FEB4C494Q47687870-FF65C87D-14B5-4DA9-AA90-142B717A1018Q48589679-BACA6856-58CA-444F-8DE3-D8F8039A1BB4Q57267915-110E6CE0-C6C0-443E-9F27-78153AE4313E
P2860
Developing the next generation of cardiac markers: disease-induced modifications of troponin I.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Developing the next generation ...... d modifications of troponin I.
@ast
Developing the next generation ...... d modifications of troponin I.
@en
type
label
Developing the next generation ...... d modifications of troponin I.
@ast
Developing the next generation ...... d modifications of troponin I.
@en
prefLabel
Developing the next generation ...... d modifications of troponin I.
@ast
Developing the next generation ...... d modifications of troponin I.
@en
P1476
Developing the next generation ...... d modifications of troponin I.
@en
P2093
Jason L McDonough
Jennifer E Van Eyk
P304
P356
10.1016/J.PCAD.2004.07.001
P577
2004-11-01T00:00:00Z